Marksans Pharma Limited has informed the Exchange regarding a press release dated August 07, 2023, titled "Completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection".
Press Release Aug 07 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Earlier from Marksans Pharma
- Press Release Jul 12 2023
- Press Release May 30 2023
- Press Release Apr 19 2023
- Press Release Mar 10 2023
- Press Release Feb 13 2023
Later from Marksans Pharma
- Press Release Aug 11 2023
- Press Release Aug 22 2023
- Press Release Oct 03 2023
- Press Release Nov 01 2023
- Press Release Nov 03 2023
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma